According to FutureWise analysis the market for angina is expected to register a CAGR of 6.1% from 2023-2031.

Angina, also referred to as angina pectoris, is a condition characterized by chest pain or discomfort resulting from insufficient oxygen-rich blood reaching a portion of the heart muscle. It is commonly associated with coronary artery disease (CAD), which is caused by the buildup of plaque—a sticky substance that accumulates in the coronary arteries. These arteries play a crucial role in supplying blood to the heart; however, plaque accumulation narrows the arteries, hampering blood flow and preventing the heart muscle from receiving the necessary oxygen and nutrients.

When medical treatment fails to alleviate angina symptoms or if the condition suddenly intensifies, more invasive procedures may be required. Options such as angioplasty or coronary artery bypass surgery provide alternatives for restoring adequate blood flow. Angioplasty is a procedure where a thin tube, known as a catheter, is inserted into an artery, typically through the groin or arm. The catheter is then carefully guided to the area in the heart that requires treatment. Once in place, a balloon at the catheter's tip is inflated, which helps compress the plaque and clear the blockage in the artery. In certain cases, this procedure may also involve placing a wire-mesh stent to ensure the artery remains open after the balloon is deflated and the catheter is removed.

FutureWise Market Research has published a report that provides an insightful analysis of Angina Market trends that are affecting the overall market growth.



Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=9243&type=requestsample

Angina Market Segmentation:

By Type

  • Beta Blockers
  • Calcium Antagonists
  • Anticoagulants
  • Antiplatelet
  • Nitrates
  • ACE inhibitors
  • Ranolazine

By Applications

  • Clinics
  • Hospitals
  • Other

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape in Angina Market:

  • Amgen
  • Taxus Cardium Pharmaceuticals
  • LegoChem Biosciences
  • Lee's Pharmaceutical
  • Milestone Pharmaceuticals
  • Juventas Therapeutics
  • ViroMed
  • Kuhnil Pharmaceutical
  • F. Hoffmann-La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Bayer AG
  • Abbott Laboratories Inc
  • Saneron CCEL Therapeutics, Inc
  • Vasomedical, Inc
  • Cryopraxis
  • Neovasc Inc
  • Ark Therapeutics Group plc

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9243&license=multi

**Objectives of this Study: **

  1. To provide a comprehensive analysis of the Angina Market By Type, By Applications and By Region.
  2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
  3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
  4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
  • The customization services offered are free of charge with the purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com